Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nancy Lee
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
215 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- London Regional Cancer Program
London, Ontario, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Mcgill University Department of Oncology
Montreal, Quebec, Canada
- the Research Institute of the Mcgill University Health Centre (muhc)
Montreal, Quebec, Canada
- Chinese University of Hong Kong-Prince of Wales Hospital
Shatin, Hong Kong, China
- Zhongshan Hospital Fudan University
Guangdong Province, Shanghai Municipality, China
- Sun Yat-Sen University Cancer Center
Guangzhou, China
- Pamela Youde Nethersole Eastern Hospital
Chai Wan, Hong Kong
- Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
- National Cancer Centre Singapore
Singapore, Singapore
- National Taiwan University Hospital
Taipei, Taiwan
- Chang Gung Hospital-Lin Kou Medical Center
Taoyuan, Taiwan
- the Kirklin Clinic at Acton Road
Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Fresno Cancer Center
Fresno, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Memorial Medical Center
Modesto, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California, United States
- Rohnert Park Cancer Center
Rohnert Park, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California, United States
- the Permanente Medical Group-Roseville Radiation Oncology
Roseville, California, United States
- South Sacramento Cancer Center
Sacramento, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Apr 2014
- Primary completion
- 28 Feb 2027
- Completion
- 28 Feb 2031
- Last update posted
- 25 Jun 2026
- Registered enrollment
- 685
- Registry id
- NCT02135042
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.